Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children

Eric Hassall1

  • 1Division of Pediatric Gastroenterology, BC Children's Hospital/University of British Columbia, Vancouver, Canada.

Insights

Gastroesophageal reflux disease (GERD) in children often presents with abdominal pain. Proton pump inhibitors (PPIs) offer a safer, effective alternative to surgery for managing GERD symptoms and esophagitis.

Area of Science:

  • Pediatric Gastroenterology
  • Acid-Related Disorders
  • Pediatric Surgery

Background:

  • Gastroesophageal reflux disease (GERD) in children commonly manifests as vomiting or esophageal symptoms, but abdominal pain is also a frequent, though less recognized, presentation.
  • While GERD and other acid-related disorders are uncommon causes of abdominal pain in school-aged children, early detection and treatment are crucial to prevent complications like failure to thrive, feeding refusal, and ENT or pulmonary issues.

Purpose of the Study:

  • To evaluate the efficacy and safety of pharmacologic management versus antireflux surgery for pediatric GERD.
  • To highlight the advantages of proton pump inhibitors (PPIs) over surgical intervention in managing GERD and its complications in children.

Main Methods:

  • Review of treatment options for persistent or severe pediatric GERD, focusing on pharmacologic therapy (PPIs) and antireflux surgery.
  • Analysis of reported outcomes, complication rates, and patient selection criteria for both medical and surgical interventions.

Main Results:

  • Proton pump inhibitors (PPIs) provide safe and effective relief of GERD symptoms and healing of esophagitis in children when administered in adequate doses.
  • Antireflux surgery in children carries significant risks, including high failure rates, recurrence of symptoms, new postoperative symptoms, and even mortality, with some studies showing over 60% of patients requiring PPIs post-surgery.
  • Many pediatric surgeries for GERD are performed with unclear indications and insufficient preoperative diagnostics, suggesting a need for more conservative approaches.

Conclusions:

  • Pharmacologic management with PPIs is a preferred and safer treatment option for many children with GERD compared to antireflux surgery.
  • Improved patient selection for surgery and the availability of effective medical therapies can lead to better outcomes and reduced surgical rates in pediatric GERD.

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...